Pre-term infants

Clinical trials for Pre-term infants explained in plain language.

Never miss a new study

Get alerted when new Pre-term infants trials appear

Sign up with your email to follow new studies for Pre-term infants, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New inhaled therapy could help preterm infants breathe easier

Disease control Recruiting now

This Phase 3 trial tests a new inhaled medication called APC-0101 in 520 premature babies born between 26 and 33 weeks who have respiratory distress syndrome. The drug is a surfactant that helps keep tiny air sacs in the lungs open. Some babies receive the active drug through a s…

Matched conditions: PRE-TERM INFANTS

Phase 3 • Sponsor: Aerogen Pharma Limited • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC

Pre-term infants

Get alerted when new Pre-term infants trials appear

New inhaled therapy could help preterm infants breathe easier